Tuesday, April 21, 2020 12:22:35 PM
a2z and tulla ,u guys were right and i was wrong.u guys were wondering why it was taking so long and i said let them get the info from tests 1st then ind will be files per kw.ooops,not.i knew the pps would crash after last 10 q and kw interview.like i said when u cant take your ceo at his word it spells big trouble,the excuse that its new fda regulations doesnt fly,even if it was new kw should have been right on top of it and said so before he said all that is needed to file ind was the info from tests.the bashers said that was just a pump and the pps rose to 6 and i said its not a pump its real news and we are finally there,not.the bashers were right again and i was dead wrong.the facts speak for themselves,also if u take forever to file ind of course the regulations change after all its been more than 3 yrs since meeting with fda.again not a good sign.throw in kw taking over a mill a yr for a startup bio who has no revenue is so out of whack its absolutely ridiculous and is another knife in the back of sh from kw.after a while even the most loyal sh say enuf already as u and i have said,hence the alltime low pps.throw in all the other times kw misled us like the we are there quote over a yr and a half ago and its way too much to ignore.im really wondering if something is wrong and if the ind will ever be filed after kw latest deception.i hope kw proves me wrong but i dont see it.ther comes a time when only results matter and we have reached that point with pmcb yesterday.im totally disgusted with kw and pmcb at this point and nobody in their right mind can argue the point afterall we are at alltime lows for a reason
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
